These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12620394)

  • 21. DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisers.
    Panserat S; Mura C; Gérard N; Vincent-Viry M; Galteau MM; Jacqz-Aigrain E; Krishnamoorthy R
    Hum Genet; 1994 Oct; 94(4):401-6. PubMed ID: 7927337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic heart failure.
    Baudhuin LM; Miller WL; Train L; Bryant S; Hartman KA; Phelps M; Larock M; Jaffe AS
    Am J Cardiol; 2010 Aug; 106(3):402-8. PubMed ID: 20643254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure.
    Sistonen J; Sajantila A; Lao O; Corander J; Barbujani G; Fuselli S
    Pharmacogenet Genomics; 2007 Feb; 17(2):93-101. PubMed ID: 17301689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous detection of single nucleotide polymorphisms and copy number variations in the CYP2D6 gene by multiplex polymerase chain reaction combined with capillary electrophoresis.
    Liao HW; Tsai IL; Chen GY; Kuo CT; Wei MF; Hwang TJ; Chen WJ; Shen LJ; Kuo CH
    Anal Chim Acta; 2013 Feb; 763():67-75. PubMed ID: 23340288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.
    Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ
    Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new simple diagnostic assay for the identification of the major CYP2D6 genotypes by DNA sequencing analysis.
    James HM; Coller JK; Gillis D; Bahnisch J; Sallustio BC; Somogyi AA
    Int J Clin Pharmacol Ther; 2004 Dec; 42(12):719-23. PubMed ID: 15624288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection.
    Hosono N; Kato M; Kiyotani K; Mushiroda T; Takata S; Sato H; Amitani H; Tsuchiya Y; Yamazaki K; Tsunoda T; Zembutsu H; Nakamura Y; Kubo M
    Clin Chem; 2009 Aug; 55(8):1546-54. PubMed ID: 19541866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
    Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of CYP2D6 polymorphisms *9, *10, and *41 using ARMS-PCR and their allelic frequencies in 400 psychiatric patients.
    Hinrichs JW; Smallegoor WD; van Baalen-Benedek EH; Welker C; van der Weide J
    Clin Chem Lab Med; 2007; 45(4):555-7. PubMed ID: 17439339
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P; Cáceres M; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
    Biotechniques; 2005 Oct; 39(10 Suppl):S571-4. PubMed ID: 18957039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis.
    Crescenti A; Mas S; Gassó P; Baiget M; Bernardo M; Lafuente A
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):992-7. PubMed ID: 17714084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events.
    Toscano C; Klein K; Blievernicht J; Schaeffeler E; Saussele T; Raimundo S; Eichelbaum M; Schwab M; Zanger UM
    Pharmacogenet Genomics; 2006 Oct; 16(10):755-66. PubMed ID: 17001295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction.
    Bathum L; Johansson I; Ingelman-Sundberg M; Hørder M; Brøsen K
    Pharmacogenetics; 1998 Apr; 8(2):119-23. PubMed ID: 10022749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3, *4, and *6) within an Iranian population (Mazandaran).
    Hashemi-Soteh SM; Sarzare F; Merat F; Salehifar E; Shiran MR
    Genet Test Mol Biomarkers; 2011 Nov; 15(11):821-5. PubMed ID: 21631295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct analysis of unphased SNP genotype data in population-based association studies via Bayesian partition modelling of haplotypes.
    Morris AP
    Genet Epidemiol; 2005 Sep; 29(2):91-107. PubMed ID: 15940704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphism of CYP2D6 in the Japanese population.
    Chida M; Yokoi T; Kosaka Y; Chiba K; Nakamura H; Ishizaki T; Yokota J; Kinoshita M; Sato K; Inaba M; Aoki Y; Gonzalez FJ; Kamataki T
    Pharmacogenetics; 1999 Oct; 9(5):601-5. PubMed ID: 10591540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP1A1 and CYP2D6 gene polymorphisms in Israeli Jewish women with cervical cancer.
    Gutman G; Morad T; Peleg B; Peretz C; Bar-Am A; Safra T; Grisaru D
    Int J Gynecol Cancer; 2009 Nov; 19(8):1300-2. PubMed ID: 20009880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13?
    Wilhelmsen K; Mirel D; Marder K; Bernstein M; Naini A; Leal SM; Cote LJ; Tang MX; Freyer G; Graziano J; Mayeux R
    Ann Neurol; 1997 Jun; 41(6):813-7. PubMed ID: 9189044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of CYP2D6 gene copy number by multiplex polymerase chain reaction analysis.
    Leandro-García LJ; Leskelä S; Montero-Conde C; Landa I; López-Jimenez E; Letón R; Seeringer A; Kirchheiner J; Cascón A; Robledo M; Rodríguez-Antona C
    Anal Biochem; 2009 Jun; 389(1):74-6. PubMed ID: 19303860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of single SNPs, haplotypes, and whole-genome LD maps on accuracy of association mapping.
    Maniatis N; Collins A; Morton NE
    Genet Epidemiol; 2007 Apr; 31(3):179-88. PubMed ID: 17285621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.